Lantheus Holdings Inc. (NASDAQ:LNTH) traded down 4.1% during mid-day trading on Wednesday . The company traded as low as $4.31 and last traded at $4.45, with a volume of 84,799 shares trading hands. The stock had previously closed at $4.64.

A number of research analysts recently commented on LNTH shares. Zacks Investment Research downgraded Lantheus Holdings from a “buy” rating to a “hold” rating in a report on Wednesday, July 6th. Jefferies Group reissued a “buy” rating on shares of Lantheus Holdings in a report on Wednesday, May 4th. Finally, Robert W. Baird reissued a “hold” rating on shares of Lantheus Holdings in a report on Monday, April 11th. Four equities research analysts have rated the stock with a hold rating and two have issued a buy rating to the company’s stock. Lantheus Holdings presently has an average rating of “Hold” and an average target price of $5.65.

The company has a 50-day moving average price of $3.54 and a 200-day moving average price of $2.49. The stock’s market cap is $136.79 million.

Lantheus Holdings (NASDAQ:LNTH) last released its quarterly earnings data on Tuesday, May 3rd. The company reported $0.34 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.06 by $0.28. The firm had revenue of $76.50 million for the quarter, compared to analyst estimates of $72.43 million. On average, analysts expect that Lantheus Holdings Inc. will post $0.35 earnings per share for the current year.

Lantheus Holdings, Inc is a holding company. The Company, through Lantheus Medical Imaging, Inc, develops, manufactures, sells and distributes diagnostic medical imaging agents and products that assist clinicians in the diagnosis of cardiovascular and other diseases. It operates in two geographical segments: U.S.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.